BrightSpring Health Services (BTSG) to Post Quarterly Earnings on Friday

BrightSpring Health Services (NASDAQ:BTSG) is projected to post its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect the company to post earnings of $0.3963 per share and revenue of $3.6606 billion for the quarter. Investors can check the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.

BrightSpring Health Services (NASDAQ:BTSG) last announced its earnings results on Friday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.10. The firm had revenue of $3.61 billion during the quarter, compared to analysts’ expectations of $3.39 billion. BrightSpring Health Services had a return on equity of 14.63% and a net margin of 2.27%.The business’s revenue was up 25.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.14 EPS. On average, analysts expect BrightSpring Health Services to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

BrightSpring Health Services Trading Up 0.1%

BTSG opened at $69.84 on Friday. The firm has a market cap of $13.78 billion, a price-to-earnings ratio of 49.53, a price-to-earnings-growth ratio of 0.88 and a beta of 1.79. BrightSpring Health Services has a 52 week low of $19.01 and a 52 week high of $73.40. The business’s 50 day moving average is $64.90 and its two-hundred day moving average is $50.65. The company has a quick ratio of 1.38, a current ratio of 1.74 and a debt-to-equity ratio of 1.24.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. UBS Group lifted their price objective on shares of BrightSpring Health Services from $63.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Weiss Ratings upgraded BrightSpring Health Services from a “hold (c)” rating to a “buy (b-)” rating in a research report on Monday, May 4th. Stephens upped their price objective on BrightSpring Health Services from $53.00 to $64.00 and gave the company an “overweight” rating in a research note on Monday, May 4th. TD Cowen lifted their target price on BrightSpring Health Services from $65.00 to $81.00 and gave the company a “buy” rating in a research note on Thursday, June 18th. Finally, KeyCorp boosted their target price on BrightSpring Health Services from $60.00 to $80.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $70.12.

Insiders Place Their Bets

In related news, insider Jon B. Rousseau sold 130,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $58.75, for a total value of $7,637,500.00. Following the completion of the sale, the insider owned 1,194,503 shares in the company, valued at $70,177,051.25. This trade represents a 9.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Lisa A. Nalley sold 35,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $58.75, for a total transaction of $2,056,250.00. Following the sale, the insider directly owned 131,948 shares in the company, valued at approximately $7,751,945. This represents a 20.96% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 2.80% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. T. Rowe Price Investment Management Inc. boosted its stake in shares of BrightSpring Health Services by 21.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,123,865 shares of the company’s stock worth $229,339,000 after acquiring an additional 1,091,757 shares in the last quarter. Invesco Ltd. grew its holdings in shares of BrightSpring Health Services by 13.4% in the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock worth $396,791,000 after acquiring an additional 1,248,107 shares during the period. Virtue Capital Management LLC increased its stake in BrightSpring Health Services by 45.9% in the 4th quarter. Virtue Capital Management LLC now owns 32,984 shares of the company’s stock valued at $1,267,000 after purchasing an additional 10,371 shares in the last quarter. State of Tennessee Department of Treasury purchased a new position in BrightSpring Health Services in the 4th quarter valued at approximately $1,915,000. Finally, Mackenzie Financial Corp purchased a new position in BrightSpring Health Services in the 4th quarter valued at approximately $252,000.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.